Weich H - Search Results

1

Selective Bacterial Targeting and Infection-Triggered Release of Antibiotic Colistin Conjugates.

Tegge W, Guerra G, Höltke A, Schiller L, Beutling U, Harmrolfs K, Gröbe L, Wullenkord H, Xu C, Weich H, Brönstrup M. Tegge W, et al. Among authors: weich h. Angew Chem Int Ed Engl. 2021 Aug 9;60(33):17989-17997. doi: 10.1002/anie.202104921. Epub 2021 Jul 5. Angew Chem Int Ed Engl. 2021. PMID: 34097810 Free PMC article.

2

Macrocyclic trichothecenes as antifungal and anticancer compounds.

de Carvalho MP, Weich H, Abraham WR. de Carvalho MP, et al. Among authors: weich h. Curr Med Chem. 2016;23(1):23-35. doi: 10.2174/0929867323666151117121521. Curr Med Chem. 2016. PMID: 26572613 Review.

3

Lymphatics and inflammation.

Wilting J, Becker J, Buttler K, Weich HA. Wilting J, et al. Among authors: weich ha. Curr Med Chem. 2009;16(34):4581-92. doi: 10.2174/092986709789760751. Curr Med Chem. 2009. PMID: 19903150 Review.

4

Development of an enzyme-linked immunoreceptor assay (ELIRA) for quantification of the biological activity of recombinant human bone morphogenetic protein-2.

Wendler J, Hoffmann A, Gross G, Weich HA, Bilitewski U. Wendler J, et al. J Biotechnol. 2005 Oct 10;119(4):425-35. doi: 10.1016/j.jbiotec.2005.04.021. J Biotechnol. 2005. PMID: 15993504

5

Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels.

Schniedermann J, Rennecke M, Buttler K, Richter G, Städtler AM, Norgall S, Badar M, Barleon B, May T, Wilting J, Weich HA. Schniedermann J, et al. BMC Cell Biol. 2010 Jul 1;11:50. doi: 10.1186/1471-2121-11-50. BMC Cell Biol. 2010. PMID: 20594323 Free PMC article.

6

Similarities and differences of human and experimental mouse lymphangiomas.

Kasten P, Schnöink G, Bergmann A, Papoutsi M, Buttler K, Rössler J, Weich HA, Wilting J. Kasten P, et al. Dev Dyn. 2007 Oct;236(10):2952-61. doi: 10.1002/dvdy.21298. Dev Dyn. 2007. PMID: 17879316 Free article.

7

Embryonic development and malformation of lymphatic vessels.

Wilting J, Buttler K, Rössler J, Norgall S, Schweigerer L, Weich HA, Papoutsi M. Wilting J, et al. Novartis Found Symp. 2007;283:220-7; discussion 227-9, 238-41. doi: 10.1002/9780470319413.ch17. Novartis Found Symp. 2007. PMID: 18300425

8

De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice.

Buttler K, Badar M, Seiffart V, Laggies S, Gross G, Wilting J, Weich HA. Buttler K, et al. Cell Mol Life Sci. 2014 Apr;71(8):1513-27. doi: 10.1007/s00018-013-1460-8. Epub 2013 Sep 1. Cell Mol Life Sci. 2014. PMID: 23995988 Free PMC article.

9

Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R, Ambati J, Wilting J. Becker J, et al. Among authors: weich ha. Clin Cancer Res. 2010 Mar 1;16(5):1431-41. doi: 10.1158/1078-0432.CCR-09-1936. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179233 Free PMC article.

10

Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.

Linke F, Harenberg M, Nietert MM, Zaunig S, von Bonin F, Arlt A, Szczepanowski M, Weich HA, Lutz S, Dullin C, Janovská P, Krafčíková M, Trantírek L, Ovesná P, Klapper W, Beissbarth T, Alves F, Bryja V, Trümper L, Wilting J, Kube D. Linke F, et al. Among authors: weich ha. Leukemia. 2017 Feb;31(2):361-372. doi: 10.1038/leu.2016.232. Epub 2016 Aug 18. Leukemia. 2017. PMID: 27535218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page